Bleeding risk assessment for venous thromboembolism prophylaxis.

Jornal Vascular Brasileiro
Maria Chiara Chindamo, Marcos Arêas Marques

Abstract

Venous thromboembolism (VTE) is one of the main preventable causes of morbidity and mortality in hospitalized patients and fatal pulmonary embolism (PE) may be its first manifestation. Several national and international guidelines recommend using risk assessment models for prescription of VTE prophylaxis in hospitalized patients. Despite evidence and guidelines supporting VTE prevention, use of VTE prophylaxis in hospitalized patients remains suboptimal, which may be because of low awareness of the benefits of VTE prophylaxis, but might also reflect fear of bleeding complications in these patients, since this constitutes one of the main reasons for underutilization of thromboprophylaxis worldwide. Bleeding risk assessment is therefore necessary for adequate prophylaxis prescription and should be carried out concurrently with assessment of the risk of thrombosis. The purpose of this review is to highlight the importance of jointly assessing risk of VTE and risk of bleeding in hospitalized patients.

References

Apr 1, 1989·Journal of the Royal Society of Medicine·D A Sandler, J F Martin
Mar 13, 1999·Archives of Internal Medicine·P M KuijerH R Büller
Aug 4, 2004·Circulation·Alain LeizoroviczUNKNOWN PREVENT Medical Thromboprophylaxis Study Group
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
May 19, 2005·Disease-a-month : DM·Joseph A Caprini
Apr 26, 2006·Journal of Thrombosis and Haemostasis : JTH·P ChopardH Bounameaux
Nov 14, 2006·Chest·Theresa I ShiremanEdward F Ellerbeck
Mar 26, 2011·Chest·Alex C SpyropoulosUNKNOWN IMPROVE Investigators
May 20, 2011·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Joseph A Caprini
Jul 16, 2011·Journal of the American College of Cardiology·Margaret C FangDaniel E Singer
Aug 31, 2012·Blood·Alex C Spyropoulos, James D Douketis
Jun 17, 2016·Thrombosis and Haemostasis·David J RosenbergAlex C Spyropoulos
Nov 2, 2016·The European Respiratory Journal·Frederikus A KlokStavros V Konstantinides
Aug 13, 2017·The American Journal of Cardiology·Hanis ZulkiflyDeirdre A Lane
May 19, 2019·Clinical Cardiology·Viviana Aursulesei, Irina Iuliana Costache
Aug 6, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nigel S KeyAnna Falanga

❮ Previous
Next ❯

Software Mentioned

IMPROVE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.